Welcome! We regret to inform you that the Injury Board National News Desk has been discontinued. Feel free to browse around and enjoy our previously published articles, or visit The Injury Blog Network for the latest in personal injury news.

Botox Might Help Migraines

Posted by Jane Akre
Thursday, September 11, 2008 11:44 AM EST
Category: Major Medical, Protecting Your Family
Tags: FDA and Prescription Drugs, Botox, Migraines, Headaches, Toxic Substances, Dangerous Products, Drug Products

Botox has shown some success in treating migraines, Allegan will likely go for approval. 



IMAGE SOURCE: ©iStockphoto/ Botox Treatment/ author: Renphoto


Allergan points to late-stage clinical data that shows its popular wrinkle-eliminator, Botox, can be used for chronic migraines.  

The announcement today had Allergan stock up nearly 13 percent.

Botox, or botulinum toxin type A, is the first therapy being investigated for chronic migraine treatment, the company says. Allergen says that patients receiving Botox experienced a significant decrease in headache days.

Phase III also showed the treatment was well tolerated.

Expect Allergan, based in Irvine, California, to apply for FDA approval to use Botox for chronic migraines by sometime next year.

An estimated 1.2 million to 3.6 million people suffer from chronic migraine headaches, according to Allergan. 

Botox Cosmetic is approved to smooth wrinkles between the eyebrows, cervical dystonia, nerve and muscle spasms, and excessive armpit sweating.

Botox injections should not be given to people at the injection site or people sensitive to any ingredients in Botox.  Heart and allergic reactions, such as difficulty swallowing, speaking, or breathing have been reported. 

In January, Public Citizen, the nonprofit watchdog group, called for a black box warning on Botox. 

Public Citizen did a safety analysis of Botox procedures from FDA records covering 1997 to 2006.  Altogether, there were 658 adverse effects from injections. 

Among those included potentially life-threatening pneumonia and fluid in the lungs and difficulty swallowing.  There were also 16 deaths. 

The data comes from drug manufacturers, so Public Citizen believes the numbers could be much higher. 

In February, stock for the popular anti-wrinkle drug Botox took a plunge, dropping 5.6 percent, after the FDA warned that some children given the drug have died.

The children who died had the brain injury cerebral palsy and were given Botox, also known as botulinum toxin, to treat spasticity in their legs. #

No Comments

Comments for this article are closed.

About the National News Desk

Our mission is to seek the complete truth and provide a full and fair account of the events and issues that surround personal safety, accident prevention, and injury recovery.  We are committed to serving the public with honesty and integrity in these efforts.

Hurt in an accident? Contact an Injury Board member

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address


RSS Feed

Add the National News Desk to your favorite RSS reader

Add to Google Reader Add to myYahoo Add to myMSN Add to Bloglines Add to Newsgator Add to Netvibes Add to Pageflakes